Trevena Inc banner

Trevena Inc
OTC:TRVN

Watchlist Manager
Trevena Inc Logo
Trevena Inc
OTC:TRVN
Watchlist
Price: 0.011 USD -8.33% Market Closed
Market Cap: $9.5k

Wall St Price Targets

TRVN Price Targets Summary
Trevena Inc

There are no price targets for TRVN.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Trevena Inc Competitors:
Price Targets
ZNTL
Zentalis Pharmaceuticals Inc
54% Upside
RLMD
Relmada Therapeutics Inc
95% Upside
CSGP
CoStar Group Inc
52% Upside
ACIU
AC Immune SA
222% Upside
QXO
SilverSun Technologies Inc
93% Upside

Revenue
Forecast

13% / Year
Past Growth
104% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
13% / Year
Past Growth
104% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 104%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TRVN's stock price target?
Not Available

TRVN does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Trevena Inc?
Projected CAGR
104%

Over the last 11 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 104%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett